Aquestive Therapeutics Inc (AQST)
3.10
-0.18
(-5.49%)
USD |
NASDAQ |
May 17, 16:00
3.10
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics Cash from Operations (Quarterly): -10.38M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -10.38M |
| December 31, 2023 | -4.942M |
| September 30, 2023 | -2.347M |
| June 30, 2023 | -7.907M |
| March 31, 2023 | 8.816M |
| December 31, 2022 | 8.416M |
| September 30, 2022 | 2.809M |
| June 30, 2022 | -6.562M |
| March 31, 2022 | -14.48M |
| December 31, 2021 | -8.061M |
| September 30, 2021 | -9.065M |
| June 30, 2021 | -1.756M |
| March 31, 2021 | -14.10M |
| December 31, 2020 | -13.51M |
| September 30, 2020 | -8.313M |
| Date | Value |
|---|---|
| June 30, 2020 | -9.997M |
| March 31, 2020 | -13.64M |
| December 31, 2019 | -10.58M |
| September 30, 2019 | -14.79M |
| June 30, 2019 | -17.17M |
| March 31, 2019 | -17.68M |
| December 31, 2018 | -2.812M |
| September 30, 2018 | -11.48M |
| June 30, 2018 | 0.511M |
| March 31, 2018 | 0.785M |
| December 31, 2017 | -7.409M |
| September 30, 2017 | 15.63M |
| June 30, 2017 | -6.302M |
| March 31, 2017 | 3.908M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-17.17M
Minimum
Jun 2019
8.816M
Maximum
Mar 2023
-7.378M
Average
-8.689M
Median
Cash from Operations (Quarterly) Benchmarks
| Lifecore Biomedical Inc | -17.29M |
| Harrow Inc | -4.628M |
| Akebia Therapeutics Inc | -19.43M |
| 89bio Inc | -39.72M |
| Humacyte Inc | -27.35M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.029M |
| Cash from Financing (Quarterly) | 81.74M |
| Free Cash Flow | -26.60M |
| Free Cash Flow Per Share (Quarterly) | -0.1415 |
| Free Cash Flow to Equity (Quarterly) | -11.66M |
| Free Cash Flow to Firm (Quarterly) | -6.542M |
| Free Cash Flow Yield | -13.01% |